Chasing New Jersey

Posted by:

CHASING NEWS : Television station WWOR solicited addiction expert, Dr. Cidambi’s opinion on Probuphine, an implantable form of buprenorphine, recently approved by the FDA. Probuphine is recommended for maintenance treatment of dependence on opiates. It is to be used to address opiate cravings and opiate withdrawal.


About the Author:

New Jersey's premier addiction treatment center, offering medically managed detox and rehabilitation treatment programs.
  Related Posts
  • No related posts found.

Add a Comment